Calidi Biotherapeutics (CLDI) Q2 2024 Earnings

May 14Confirmed
Q2 2024
-2.75
-2.5
-2.25
-2

Details

Expected EPS
-2.75
Actual EPS
-2
Surprise EPS
0.75
Surprise Percent
+27.27%

Description

⁨Calidi Biotherapeutics⁩ (⁦CLDI⁩) has reported earnings of ⁦-2⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts